A Phase II Study of Pazopanib With Oral Topotecan in Patients With Metastatic and Non-resectable Soft Tissue and Bone Sarcomas
Phase of Trial: Phase II
Latest Information Update: 11 Jan 2018
At a glance
- Drugs Pazopanib (Primary) ; Topotecan (Primary)
- Indications Liposarcoma; Osteosarcoma; Soft tissue sarcoma
- Focus Therapeutic Use
- 08 Jan 2018 Planned End Date changed from 1 Jul 2017 to 1 Jun 2020.
- 08 Jan 2018 Planned primary completion date changed from 1 Jul 2017 to 1 Jul 2019.
- 10 Jun 2017 Biomarkers information updated